Product Reports Resources Pricing Login Book a demo

Janssen Vaccines

Biotech & Life Sciences · Leiden, Netherlands · Founded 2000 · IPO 2000

Vaccine development and manufacturing using proprietary platforms

Revenue $60B

Talent graph

Janssen Vaccines's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 9 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Janssen Vaccines's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series B+ 1 investor entered at this stage
Leiden University

Global footprint

Where Janssen Vaccines has talent and traffic

Workforce by country
🇳🇱 Netherlands · Leiden HQ
Book a demo for the full country breakdown
Web traffic by country
11K monthly visits
across markets
🇵🇱 Poland50%
🇺🇸 United States41.8%
🇯🇵 Japan7.3%
🇲🇽 Mexico1.8%
🇬🇷 Greece0.9%
Top 5 markets shown

Patent intelligence

Janssen Vaccines’s patent portfolio

Estimated portfolio value
$7.1B

3,990 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Market sentiment

What the market is saying about Janssen Vaccines

An AI-synthesized read of the highest-engagement posts about Janssen Vaccines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Janssen Vaccines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.